CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,028 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02641015
NCT02641015N/ACompleted
CompareCT.gov

A Retrospective Observational Study to Assess the Clinical Management and Outcomes of Hospitalised Patients With Complicated Urinary Tract Infection in Countries With High Prevalence of Multidrug Resistant Gram-negative Bacteria.

Institut d'Investigació Biomèdica de Bellvitge·observational·Posted Dec 29, 2015·Updated Jan 18, 2017

In Brief

An observational study for Urinary Tract Infections and Bacterial Resistance. Completed, enrolled 1,028 participants across 21 sites in 8 countries.

Detailed Summary

A retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant gram-negative bacteria (COMBACTE-MAGNET,WP5)

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Tract Infections, Bacterial Resistance
CountriesBulgaria, Greece, Hungary, Israel, Italy, Romania, Spain, Turkey (Türkiye)
CollaboratorsTel Aviv University, AiCuris Anti-infective Cures AG, University of Bristol, UMC Utrecht

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 29, 2015
Enrollment StartDec 1, 2015
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.5 years ago